PSMA PET/CT | Department of Medicine Blog

Prostate-Specific Membrane Antigen PET/CT Complements MRI for Focal Therapy Selection in Prostate Cancer: A Whole-Mount Histopathologic Study

Sonni I, Mohammadigoldar Z, Furey G, Kimura K, Movva PC, Holzgreve A, Bahri S, Sevco T, Chung A, Sisk A, Grogan T, Czernin J, Sung[...]

By afschroeder • October 30, 2026

Early detection and localization of recurrent prostate cancer using [Formula: see text]F-DCFPyL PET/CT in patients with low and ultra-low PSA levels

Sonni I, Gulpe A, Nickols NG, Schaffer D, Montagut L, Berenji GR, Rettig MB. Early detection and localization of recurrent prostate cancer using [Formula: see[...]

By afschroeder • July 28, 2026

PSMA PET/CT-Derived Indicators and Outcomes After [177Lu]Lu-PSMA-617: A Multicenter Retrospective Analysis from the U.S. Expanded-Access Program

Kimura K, Murthy V, Voter AF, Solnes LB, Moradi Tuchayi A, Yadav S, Theus L, Nguyen A, Ludwig V, Holzgreve A, Unterrainer LM, Grogan TR,[...]

By afschroeder • February 13, 2026

Clinical, Pathologic, and Imaging Variables Associated with Prostate Cancer Detection by PSMA PET/CT and Multiparametric MRI

Sonni I, Weiner AB, Doddipalli S, Deol M, Ban D, Kim HO, Grogan T, Ahuja P, Barroso N, Zong Y, Soin P, Sisk A, Czernin[...]

By sjmartinez • October 31, 2024